Comparison of differing C-reactive protein assay methods and their impact on cardiovascular risk assessment

Jessica L Clarke1, Jeffrey L Anderson, John F Carlquist

  • 1Cardiovascular Department, LDS Hospital, Salt Lake City, Utah 84143, USA.

Insights

Medium-sensitivity C-reactive protein (CRP) assays correlate highly with high-sensitivity methods for predicting cardiac events. While absolute values differ, quartile ranks remain similar, validating prior research findings.

Area of Science:

  • Clinical Chemistry
  • Cardiovascular Medicine
  • Biomarker Assays

Background:

  • C-reactive protein (CRP) is a key biomarker for inflammation and cardiovascular risk.
  • Assessing CRP levels aids in predicting adverse cardiovascular events like myocardial infarction.
  • Different assay sensitivities exist, potentially impacting clinical interpretation.

Purpose of the Study:

  • To compare a medium-sensitivity CRP assay with a high-sensitivity assay in a patient cohort.
  • To evaluate the concordance of predictive values for mortality and myocardial infarction between the two assay types.
  • To determine the validity of conclusions from previous studies using medium-sensitivity CRP assays.

Main Methods:

  • A cohort of 803 patients undergoing coronary angiography was studied.
  • A medium-sensitivity CRP assay was compared against a high-sensitivity, enhanced immunoturbidimetric assay.
  • Statistical analysis focused on absolute values, quartile ranks, and predictive values for clinical outcomes.

Main Results:

  • Significant differences in absolute CRP values were observed between the two assays.
  • A high correlation was found when data was analyzed by quartile rank.
  • Both assays demonstrated similar predictive values for death and myocardial infarction.

Conclusions:

  • Conclusions from previous studies using medium-sensitivity CRP assays remain valid.
  • Cross-study comparisons of CRP data should utilize percentile ranks rather than absolute values.
  • High-sensitivity CRP assays provide comparable prognostic information to medium-sensitivity assays for cardiovascular risk stratification.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...